The architecture of the system rests on three converging technological pillars: large language models, automated reasoning, and laboratory automation. Large language models provide the flexible, generative capacity to read and synthesize scientific text, propose ideas, and communicate conclusions. Automated reasoning supplies the logical machinery to check that proposed hypotheses and experimental designs are internally consistent and grounded in established knowledge. Laboratory automation, embodied in robotic platforms, translates digital plans into physical experiments. By wiring these components together into a feedback loop, the Chalmers team created a system in which the output of one stage becomes the input of the next, and the results of each experiment feed back into the AI’s evolving understanding of the biological system under study.

Crucially, the AI did not start from a blank slate. The researchers supplied it with a substantial body of scientific knowledge about its experimental subject, including the genome of Saccharomyces cerevisiae, the metabolic pathways that govern its biochemistry, and the accumulated findings of previous studies. Yeast is an ideal proving ground for such a system because its genetics and metabolism have been mapped in extraordinary detail over decades of research, yet the sheer volume of that knowledge now exceeds what any individual scientist can hold in mind, let alone analyze systematically. It is precisely this information overload that the AI scientist was designed to exploit.

Ievgeniia Tiukova, a postdoctoral researcher at the Department of Life Sciences at Chalmers and one of the authors of the new study, explained the scale of the challenge. It is too much information for a human to analyze, she noted, but the AI scientist could identify promising biological questions, recommend experiments to test them, evaluate experimental outcomes, and iteratively refine its understanding based on new evidence. In her view, the most important shift is conceptual: rather than serving solely as decision-support tools, the AI scientist actively generates new scientific knowledge. That distinction separates this system from the many AI assistants that help researchers search literature or analyze data after the fact, because here the machine sits at the center of the discovery process itself.

Integrating the thinking power of AI with genuine experimental capability remains unusual, even within the rapidly expanding field of autonomous research systems. Many projects combine intelligent planning with robotic execution in chemistry or materials science, but validated autonomous discovery in systems biology, where the object of study is a living cell with thousands of interacting components, pushes the approach into far more complex territory. Tiukova draws an analogy to the development of self-driving cars, where AI and machine learning are used to process information, draw conclusions, and take action in the physical world. In the same way, an autonomous laboratory must perceive the state of its experiments, decide what to do next, and act, all while remaining accountable to the standards of scientific evidence.

The physical side of the platform carries a distinguished pedigree. The robot scientist Eve, shown in imagery released with the study, was originally designed specifically for drug discovery and has now been updated with large language models and automated reasoning. Eve’s lineage traces back to Adam, the first general-purpose robot scientist, developed by Ross King, who is now Professor at the Department of Computer Science and Engineering at Chalmers and the University of Gothenburg and the senior author of the new study. Adam was built to autonomously carry out scientific experiments and generate new knowledge, and Eve followed as a second-generation system aimed at accelerating the search for new medicines. The underlying concept of using robotic systems to automate and accelerate scientific discovery has since spread to other areas of research, including chemistry and a range of specialized scientific tasks, making the Chalmers work part of a broader movement that has been gathering momentum for nearly two decades.

King believes the implications for the pace of science are profound. Autonomous laboratories, he argues, will revolutionize research by systematically investigating biological systems much faster than is possible today. AI scientists will collaborate with human scientists to accelerate discoveries across biology, medicine and biotechnology, and such systems have the potential to reduce the time required to explore complex scientific questions while optimizing the use of laboratory resources. The argument is one of throughput: a robotic laboratory does not tire, does not need sleep, and can execute carefully planned experimental cycles around the clock, compressing into weeks a search through experimental conditions that might occupy a human-led team for months or years.

Both Tiukova and King are careful to frame the technology as augmentation rather than replacement. For now, autonomous AI will increasingly undertake the routine cycles of hypothesis generation and experimental testing, the repetitive engine room of experimental science, while human scientists remain essential for defining research priorities, interpreting the broader scientific significance of results, and ensuring ethical oversight. King adds that future generations of autonomous discovery systems will become increasingly capable of collaborating with human scientists, becoming valuable partners in addressing some of the most challenging questions in biology and medicine. The division of labor he envisions is complementary: machines excel at exhaustive, systematic exploration of well-defined hypothesis spaces, while humans supply judgment, context, and the sense of which questions matter.

The study, titled Agentic AI integrated with scientific knowledge: laboratory validation in systems biology, was authored by Daniel Brunnsåker, Alexander H. Gower, Prajakta Naval, Erik Y. Bjurström, Filip Kronström, Ievgeniia A. Tiukova and Ross D. King, with researchers affiliated with Chalmers University of Technology, the University of Gothenburg and the University of Cambridge in the United Kingdom. The work received funding from the Wallenberg AI, Autonomous Systems and Software Program (WASP), the UK Engineering and Physical Sciences Research Council, the Chalmers AI Research Centre (CHAIR), and the Swedish Research Council for Sustainable Development, Formas. The authors declare no competing interests.

What makes the Chalmers result resonate beyond the laboratory is the way it reframes the role of AI in science. For years, the public conversation has centered on AI as a tool for analyzing data or drafting text. A closed-loop AI scientist is something categorically different: an agent that closes the circle between idea, experiment, and evidence, and does so in the messy, unforgiving domain of living cells. If autonomous laboratories can reliably generate and validate biological discoveries with minimal human intervention, the bottleneck in research may shift from the capacity to run experiments to the wisdom of choosing which questions to ask, a bottleneck that will remain, for the foreseeable future, firmly in human hands.

Subject of Research: Autonomous AI-driven hypothesis generation and experimental validation in systems biology using brewer's yeast

Article Title: AI scientist autonomously generates and validates new biological discoveries

Article References: AI scientist autonomously generates and validates new biological discoveries. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: artificial intelligence, autonomous laboratories, robot scientist, systems biology, Saccharomyces cerevisiae, large language models, automated reasoning, laboratory automation, drug discovery, self-driving laboratories, hypothesis generation, Chalmers University of Technology